Mi-Helper Transnasal Cooling for Acute Treatment of Migraine

NACompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

June 18, 2024

Study Completion Date

September 24, 2024

Conditions
Episodic MigraineMigraine With AuraMigraine Without AuraMigraine
Interventions
DEVICE

Mi-Helper

The Mi-Helper device is a non-invasive, drug-free, novel therapy that uses a patented process of dry air flow across the nasal turbinates to induce a phase change (evaporation) that extracts energy (thermodynamics) causing local cooling which modulates nerves associated with pain and other symptoms of migraine. The device delivers a controlled pressure and flow of dry room temperature air along with a nebulized saline mist for added comfort and evaporative efficiency.

Trial Locations (1)

10001

ObvioHealth, New York

All Listed Sponsors
collaborator

ObvioHealth

INDUSTRY

lead

CoolTech LLC

INDUSTRY

NCT06051604 - Mi-Helper Transnasal Cooling for Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter